Recombinant CD40 (Vanalimab Biosimilar) antibody
The Humanized Chimeric anti-CD40 (Vanalimab Biosimilar) antibody (ABIN7598081) specifically detects CD40 (Vanalimab Biosimilar).
The antibody is reactive with Human samples.
Catalog No. ABIN7598081
$357.68
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant CD40 (Vanalimab Biosimilar) antibody (ABIN7598081)
Target
CD40 (Vanalimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Vanalimab Biosimilar Antibody
-
Specificity
- Tumor necrosis factor receptor superfamily member 5, B-cell surface antigen CD40, Bp50, CD40L receptor, TNFRSF5, CDw40, CD40
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 lambda
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- CD40 (Vanalimab Biosimilar)
-
Alternative Name
- Vanalimab Biosimilar
-
Target Type
- Biosimilar
-
Background
- Tumor necrosis factor receptor superfamily member 5, B-cell surface antigen CD40, Bp50, CD40L receptor, TNFRSF5, CDw40, CD40
-
UniProt
- P25942
-
CAS-No
- 2055640-86-1
Target
-
You are here:
